Palatin Technologies Stock Price, News & Analysis (NYSEAMERICAN:PTN)

$0.89 0.00 (-0.45 %)
(As of 01/21/2018 03:15 AM ET)
Previous Close$0.89
Today's Range$0.87 - $0.90
52-Week Range$0.29 - $1.05
Volume713,281 shs
Average Volume1.29 million shs
Market Capitalization$168.39 million
P/E Ratio17.70
Dividend YieldN/A

About Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies logoPalatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company's primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD), which is a type of female sexual dysfunction (FSD) defined as low desire with associated distress. Its other drug development programs include Melanocortin receptor-4 (MC4r), PL-3994 and Melanocortin receptor-1 (MC1r). MC4r is a compound used for treatment of obesity and diabetes. PL-3994 is a subcutaneously injected guanylate-cyclase type A (GC-A) receptor agonist. MC1r agonist peptides are used for treatment of inflammatory and dermatologic disease indications.

Receive PTN News and Ratings via Email

Sign-up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio17.7
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$0.05
Net IncomeN/A
Net Margins39.36%
Return on Equity10,489.06%
Return on Assets79.22%


Outstanding Shares190,310,000

Palatin Technologies (NYSEAMERICAN:PTN) Frequently Asked Questions

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) posted its earnings results on Monday, November, 13th. The biopharmaceutical company reported $0.05 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.06 by $0.01. The biopharmaceutical company had revenue of $26.94 million for the quarter, compared to the consensus estimate of $28 million. Palatin Technologies had a net margin of 39.36% and a return on equity of 10,489.06%. During the same period last year, the company posted ($0.08) earnings per share. View Palatin Technologies' Earnings History.

Where is Palatin Technologies' stock going? Where will Palatin Technologies' stock price be in 2018?

2 equities research analysts have issued twelve-month price objectives for Palatin Technologies' shares. Their forecasts range from $2.00 to $6.00. On average, they anticipate Palatin Technologies' stock price to reach $4.00 in the next twelve months. View Analyst Ratings for Palatin Technologies.

Are investors shorting Palatin Technologies?

Palatin Technologies saw a increase in short interest during the month of December. As of December 29th, there was short interest totalling 5,030,680 shares, an increase of 2.2% from the December 15th total of 4,923,874 shares. Based on an average trading volume of 893,410 shares, the days-to-cover ratio is presently 5.6 days. Approximately 2.8% of the shares of the stock are short sold.

Who are some of Palatin Technologies' key competitors?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:

  • John K. A. Prendergast Ph.D., Chairman of the Board (Age 63)
  • Carl Spana Ph.D., President, Chief Executive Officer, Director (Age 53)
  • Stephen T. Wills CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary (Age 59)
  • Anthony M. Manning Ph.D., Director (Age 55)
  • Robert K. deVeer Jr., Independent Director (Age 70)
  • Alan William Dunton M.D., Independent Director (Age 61)
  • Zola P. Horovitz Ph.D., Independent Director (Age 80)
  • Joseph Stanley Hull, Independent Director (Age 64)

Who owns Palatin Technologies stock?

Palatin Technologies' stock is owned by a number of of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (0.66%). View Institutional Ownership Trends for Palatin Technologies.

Who bought Palatin Technologies stock? Who is buying Palatin Technologies stock?

Palatin Technologies' stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC. View Insider Buying and Selling for Palatin Technologies.

How do I buy Palatin Technologies stock?

Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of Palatin Technologies stock can currently be purchased for approximately $0.89.

How big of a company is Palatin Technologies?

Palatin Technologies has a market capitalization of $168.39 million.

How can I contact Palatin Technologies?

Palatin Technologies' mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company can be reached via phone at +1-609-4952200.

MarketBeat Community Rating for Palatin Technologies (PTN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  176 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  286
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Palatin Technologies (NYSEAMERICAN:PTN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$3.75$2.68
Price Target Upside: 422.74% upside422.74% upside514.75% upside650.58% upside

Palatin Technologies (NYSEAMERICAN:PTN) Consensus Price Target History

Price Target History for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN:PTN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
11/13/2017Canaccord GenuitySet Price TargetBuy$6.00View Rating Details
10/29/2017Roth CapitalSet Price TargetBuy$2.00View Rating Details
9/22/2016S&P Equity ResearchLower Price Target$0.61 -> $0.55View Rating Details
(Data available from 1/21/2016 forward)


Palatin Technologies (NYSEAMERICAN:PTN) Earnings History and Estimates Chart

Earnings by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN PTN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q1 18$0.06$0.05$28.00 million$26.94 millionViewN/AView Earnings Details
9/25/2017Q4 17($0.02)$0.07$18.54 million$33.90 millionViewN/AView Earnings Details
5/18/2017Q3 2017$0.10($0.02)$60.00 million$10.82 millionViewN/AView Earnings Details
2/9/2017Q2 2017($0.07)($0.06)ViewListenView Earnings Details
11/15/2016Q117($0.08)($0.08)ViewN/AView Earnings Details
9/20/2016Q416($0.08)($0.09)ViewListenView Earnings Details
5/17/2016Q316($0.08)($0.08)ViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.08)ViewN/AView Earnings Details
11/12/2015Q116($0.08)($0.08)ViewListenView Earnings Details
9/21/2015Q415($0.06)($0.09)$2.05 million$12.95 millionViewListenView Earnings Details
5/13/2015Q315($0.04)($0.07)$0.41 millionViewListenView Earnings Details
2/13/2015Q115$0.01$0.03$5.40 million$4.90 millionViewN/AView Earnings Details
11/18/2014Q1 15$0.04$0.01$9.00 million$4.93 millionViewN/AView Earnings Details
9/9/2014Q4 14$0.03($0.04)ViewN/AView Earnings Details
5/13/2014Q3($0.03)($0.01)$500.00 millionViewListenView Earnings Details
2/18/2014Q2 2014($0.04)($0.03)ViewN/AView Earnings Details
11/14/2013Q1($0.05)($0.04)ViewListenView Earnings Details
10/1/2013Q413($0.05)($0.04)ViewListenView Earnings Details
5/14/2013Q3 2013($0.05)($0.04)$0.02 millionViewListenView Earnings Details
2/14/2013Q2 2013$0.01($0.02)ViewN/AView Earnings Details
11/14/2012Q1 2013($0.16)($0.09)ViewN/AView Earnings Details
9/11/2012Q4 2012($0.10)($0.14)ViewN/AView Earnings Details
5/14/2012Q3 2012($0.13)($0.17)ViewN/AView Earnings Details
2/15/2012Q2 2012($0.09)($0.08)ViewN/AView Earnings Details
11/15/2011Q1 2012($0.10)($0.10)ViewN/AView Earnings Details
9/22/2011Q4 2011($0.08)($0.13)ViewN/AView Earnings Details
5/16/2011Q3 2011($0.11)ViewN/AView Earnings Details
2/15/2011Q2 2011($0.09)ViewN/AView Earnings Details
11/15/2010Q1 2011($0.39)ViewN/AView Earnings Details
9/27/2010Q4 2010($3.95)ViewN/AView Earnings Details
5/13/2010Q3 2010($0.20)ViewN/AView Earnings Details
2/16/2010Q2 2010$0.44ViewN/AView Earnings Details
9/8/2009Q4 2009($0.02)ViewN/AView Earnings Details
5/15/2009Q3 2009$0.20$0.01ViewN/AView Earnings Details
2/17/2009Q2 2009$0.20($0.04)ViewN/AView Earnings Details
11/17/2008Q1 2009($0.50)ViewN/AView Earnings Details
9/30/2008Q4 2008($0.60)ViewN/AView Earnings Details
5/13/2008Q3 2008($0.40)($0.60)ViewN/AView Earnings Details
2/8/2008Q2 2008($1.00)($0.40)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Palatin Technologies (NYSEAMERICAN:PTN) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Palatin Technologies (NYSEAMERICAN:PTN)

No dividend announcements for this company have been tracked by

Insider Trades

Palatin Technologies (NYSEAMERICAN PTN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)
Institutional Ownership by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN PTN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2015Joseph Stanley HullDirectorBuy2,500$0.66$1,650.0021,500View SEC Filing  
10/2/2015Robert K Deveer JrDirectorBuy10,000$0.82$8,200.00222,393View SEC Filing  
2/26/2014Bvf Partners L P/IlMajor ShareholderSell540,181$1.14$615,806.34View SEC Filing  
2/19/2014Bvf Partners L P/IlMajor ShareholderSell305,966$1.17$357,980.22View SEC Filing  
3/19/2013Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
2/1/2013Alan W DuntonDirectorBuy2,000$0.59$1,180.00View SEC Filing  
1/28/2013Robert I TaberDirectorBuy5,000$0.59$2,950.00View SEC Filing  
12/31/2012Carl SpanaCEOBuy10,000$0.57$5,700.00View SEC Filing  
12/28/2012Stephen T WillsCFOBuy10,000$0.56$5,600.00View SEC Filing  
12/24/2012Perry B MolinoffDirectorBuy10,000$0.61$6,100.00View SEC Filing  
12/14/2012Robert K Deveer JrDirectorBuy21,960$0.70$15,372.00View SEC Filing  
9/4/2012Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Palatin Technologies (NYSEAMERICAN PTN) News Headlines


SEC Filings

Palatin Technologies (NYSEAMERICAN:PTN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Palatin Technologies (NYSEAMERICAN:PTN) Income Statement, Balance Sheet and Cash Flow Statement


Palatin Technologies (NYSEAMERICAN PTN) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.